Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Hair follicles in the back of the rosette fancy mouse have reversed orientations due to a gene mutation.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

More research is needed to understand and manage angioedema in pregnant women with lupus.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

Tailored combination therapy improves non-scarring alopecia outcomes.

Latanoprost is more effective than minoxidil for treating alopecia areata.